Loading clinical trials...
Loading clinical trials...
Primary Outcome Measures:Incidence density of colonization with MRSA or VRE (number of new colonization events per 1000 patient days at risk) during the intervention phase. Secondary Outcome Measures:...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NCT06833957 · Group B Streptococcus, Invasive Bacterial Diseases (IBD), and more
NCT02034279 · Advanced Chronic Liver Disease, Urinary Infection, and more
NCT01586169 · Parasitic Diseases, Bacterial Diseases
University of Alabama at Birmingham
Birmingham, Alabama
Mayo Clinic Arizona
Scottsdale, Arizona
University of Arizona Health Sciences Center
Tucson, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions